ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 213 filers reported holding ISHARES TR in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,983,116 | -1.8% | 30,166 | +0.1% | 0.01% | 0.0% |
Q2 2023 | $3,037,048 | -6.6% | 30,132 | -5.8% | 0.01% | 0.0% |
Q1 2023 | $3,252,916 | +89413.4% | 31,998 | -8.2% | 0.01% | -20.0% |
Q4 2022 | $3,634 | -99.9% | 34,866 | -29.2% | 0.01% | -23.1% |
Q3 2022 | $4,496,000 | +3.8% | 49,250 | +14.2% | 0.01% | +8.3% |
Q2 2022 | $4,330,000 | +25.4% | 43,115 | +33.5% | 0.01% | +33.3% |
Q1 2022 | $3,452,000 | -6.7% | 32,295 | -11.9% | 0.01% | 0.0% |
Q4 2021 | $3,701,000 | +3.6% | 36,649 | -3.3% | 0.01% | 0.0% |
Q3 2021 | $3,573,000 | -58.6% | 37,911 | -57.6% | 0.01% | -59.1% |
Q2 2021 | $8,636,000 | +2.0% | 89,464 | +0.3% | 0.02% | -8.3% |
Q1 2021 | $8,466,000 | +5.8% | 89,219 | -2.2% | 0.02% | 0.0% |
Q4 2020 | $8,001,000 | +6.9% | 91,264 | -1.8% | 0.02% | -7.7% |
Q3 2020 | $7,483,000 | -1.1% | 92,974 | -0.2% | 0.03% | -7.1% |
Q2 2020 | $7,563,000 | +16.9% | 93,192 | +3.1% | 0.03% | -6.7% |
Q1 2020 | $6,468,000 | -22.1% | 90,401 | +6.7% | 0.03% | 0.0% |
Q4 2019 | $8,308,000 | +10.7% | 84,717 | +6.3% | 0.03% | 0.0% |
Q3 2019 | $7,507,000 | -3.4% | 79,719 | -3.0% | 0.03% | 0.0% |
Q2 2019 | $7,769,000 | +556.7% | 82,202 | +548.2% | 0.03% | +328.6% |
Q1 2019 | $1,183,000 | -49.4% | 12,681 | -54.3% | 0.01% | -56.2% |
Q4 2018 | $2,339,000 | -9.1% | 27,725 | -1.9% | 0.02% | 0.0% |
Q3 2018 | $2,573,000 | +8.4% | 28,261 | +1.2% | 0.02% | 0.0% |
Q2 2018 | $2,374,000 | -13.5% | 27,932 | -14.0% | 0.02% | -15.8% |
Q1 2018 | $2,744,000 | -5.2% | 32,480 | +1.1% | 0.02% | -9.5% |
Q4 2017 | $2,895,000 | +10.8% | 32,121 | +5.6% | 0.02% | +5.0% |
Q3 2017 | $2,613,000 | +31.7% | 30,404 | +27.4% | 0.02% | +25.0% |
Q2 2017 | $1,984,000 | -0.9% | 23,866 | -0.1% | 0.02% | 0.0% |
Q1 2017 | $2,003,000 | -1.9% | 23,887 | -3.8% | 0.02% | -11.1% |
Q4 2016 | $2,041,000 | +2.4% | 24,820 | +1.2% | 0.02% | 0.0% |
Q3 2016 | $1,994,000 | +1.8% | 24,534 | +4.2% | 0.02% | 0.0% |
Q2 2016 | $1,958,000 | +5.5% | 23,554 | -1.0% | 0.02% | 0.0% |
Q1 2016 | $1,856,000 | +75.1% | 23,792 | +64.8% | 0.02% | +63.6% |
Q4 2015 | $1,060,000 | +307.7% | 14,440 | +286.9% | 0.01% | +266.7% |
Q3 2015 | $260,000 | +3.6% | 3,732 | +9.2% | 0.00% | +50.0% |
Q2 2015 | $251,000 | – | 3,417 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVS HEALTH Corp | 624,536 | $62,722,000 | 52.01% |
Angeles Investment Advisors, LLC | 2,162,920 | $217,222,000 | 19.86% |
Bull Oak Capital, LLC | 162,500 | $16,320,000 | 15.09% |
Essex Private Wealth Management, LLC | 38,182 | $3,835,000 | 14.33% |
VAUGHAN & Co SECURITIES, INC. | 145,498 | $14,612,000 | 11.71% |
SWISS RE LTD | 564,820 | $56,725,000 | 11.35% |
Rain Capital Management, LLC | 133,852 | $13,443,000 | 9.66% |
Titus Wealth Management | 189,826 | $19,064,000 | 9.55% |
MCIA Inc | 182,506 | $18,400,000 | 9.20% |
Prostatis Group LLC | 55,911 | $5,615,175 | 8.75% |